Precision Biosciences (DTIL) Enterprise Value (2018 - 2025)
Precision Biosciences (DTIL) has disclosed Enterprise Value for 8 consecutive years, with -$44.9 million as the latest value for Q3 2025.
- On a quarterly basis, Enterprise Value rose 55.66% to -$44.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$44.9 million, a 55.66% increase, with the full-year FY2024 number at -$86.3 million, up 26.03% from a year prior.
- Enterprise Value was -$44.9 million for Q3 2025 at Precision Biosciences, up from -$77.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$44.9 million in Q3 2025 to a low of -$212.1 million in Q3 2022.
- A 5-year average of -$137.7 million and a median of -$137.8 million in 2023 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: crashed 59.98% in 2021, then surged 55.66% in 2025.
- Precision Biosciences' Enterprise Value stood at -$143.7 million in 2021, then plummeted by 31.96% to -$189.6 million in 2022, then soared by 38.45% to -$116.7 million in 2023, then grew by 26.03% to -$86.3 million in 2024, then skyrocketed by 48.01% to -$44.9 million in 2025.
- Per Business Quant, the three most recent readings for DTIL's Enterprise Value are -$44.9 million (Q3 2025), -$77.2 million (Q1 2025), and -$86.3 million (Q4 2024).